JPMorgan Chase & Co. - Net Worth and Insider Trading
JPMorgan Chase & Co. Net Worth
The estimated net worth of JPMorgan Chase & Co. is at least $61 Million dollars as of 2025-05-25. JPMorgan Chase & Co. is the 2201 Interest of corporation controlled by you of Shandong Xinhua Pharmaceutical Co Ltd and owns about 10,264,200 shares of Shandong Xinhua Pharmaceutical Co Ltd (HKSE:00719) stock worth over $61 Million. Details can be seen in JPMorgan Chase & Co.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that JPMorgan Chase & Co. has not made any transactions after 2023-02-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of JPMorgan Chase & Co.
JPMorgan Chase & Co. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, JPMorgan Chase & Co. owns 1 companies in total, including Shandong Xinhua Pharmaceutical Co Ltd (HKSE:00719) .
Click here to see the complete history of JPMorgan Chase & Co.’s form 4 insider trades.
Insider Ownership Summary of JPMorgan Chase & Co.
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:00719 | Shandong Xinhua Pharmaceutical Co Ltd | 2023-02-02 | 2201 Interest of corporation controlled by you |
JPMorgan Chase & Co. Latest Holdings Summary
JPMorgan Chase & Co. currently owns a total of 1 stock. JPMorgan Chase & Co. owns 10,264,200 shares of Shandong Xinhua Pharmaceutical Co Ltd (HKSE:00719) as of February 2, 2023, with a value of $61 Million.
Latest Holdings of JPMorgan Chase & Co.
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:00719 | Shandong Xinhua Pharmaceutical Co Ltd | 2023-02-02 | 10,264,200 | 5.99 | 61,482,558 |
Holding Weightings of JPMorgan Chase & Co.
JPMorgan Chase & Co. Form 4 Trading Tracker
According to the SEC Form 4 filings, JPMorgan Chase & Co. has made a total of 28 transactions in Shandong Xinhua Pharmaceutical Co Ltd (HKSE:00719) over the past 5 years, including 7 buys and 3 sells. The most-recent trade in Shandong Xinhua Pharmaceutical Co Ltd is the acquisition of 1,032,000 shares on February 2, 2023, which cost JPMorgan Chase & Co. around $7 Million.
Insider Trading History of JPMorgan Chase & Co.
- 1
JPMorgan Chase & Co. Trading Performance
GuruFocus tracks the stock performance after each of JPMorgan Chase & Co.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by JPMorgan Chase & Co. is -29.19%. GuruFocus also compares JPMorgan Chase & Co.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by JPMorgan Chase & Co. within 3 months outperforms 0 times out of 7 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how JPMorgan Chase & Co.'s insider trading performs compared to the benchmark.
Performance of JPMorgan Chase & Co.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -26.82 | | | | | |
| Relative Return to S&P 500(%) | -28.67 | | | | | |
JPMorgan Chase & Co. Ownership Network
Ownership Network List of JPMorgan Chase & Co.
Ownership Network Relation of JPMorgan Chase & Co.
JPMorgan Chase & Co. Owned Company Details
What does Shandong Xinhua Pharmaceutical Co Ltd do?
Who are the key executives at Shandong Xinhua Pharmaceutical Co Ltd?
JPMorgan Chase & Co. is the 2201 Interest of corporation controlled by you of Shandong Xinhua Pharmaceutical Co Ltd. Other key executives at Shandong Xinhua Pharmaceutical Co Ltd include and 2101 Beneficial owner Hua Lu Kong Gu Ji Tuan You Xian Gong Si .
Shandong Xinhua Pharmaceutical Co Ltd (HKSE:00719) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Shandong Xinhua Pharmaceutical Co Ltd (HKSE:00719) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shandong Xinhua Pharmaceutical Co Ltd (HKSE:00719) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Shandong Xinhua Pharmaceutical Co Ltd (HKSE:00719)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shandong Xinhua Pharmaceutical Co Ltd Insider Transactions
JPMorgan Chase & Co. Mailing Address
Above is the net worth, insider trading, and ownership report for JPMorgan Chase & Co.. Currently GuruFocus does not have mailing address information for JPMorgan Chase & Co..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
